3Reves JG.Educational considerations for the clinical introduction and use of remifentanil.Anesth Analg,1999,89:S4-6.
4Glass PS,Gan TJ,Howell S.A review of the pharmacokinetics and pharmacodynamics of remifentanil.Anesth Analg,1999,89 :S7-14.
5Guy J,Hindman BJ,Baker KZ,et al.Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions.Anesthesiology,1997,86:514-524.
6Guy J,Warner DS,Kirchner J,et al.Emergence/recovery profile of neurosurgical patients following remifentanil/N2O anesthesia.Anesth Analg,1996,82:S151.
8Kazmaier S,Hanekop GG,Buhre W,et al.Myocardial consequences of remifentanil in patients with coronary artery disease.Br J Anaesth,2000,84:578-583.
9Unlugenc H,Itegin M,Ocal L,et al.Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips.Acta Anaesthesiol Scand,2003,47:65-69.
10Drazner MH,Thompson B,Rosenberg PB,et al.Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic caridomyopathy.Am J Cardiol,2002,89:993-995.
8Albertin A,Casati A,Deni F,et al.Clinical comparison of either small doses of fentanil or remifentanil for bluntingcardiovascular changes induced by tracheal intubatrion.Minerva Anaesthesia,2000,66:691-696.
9Brockrnarm C,Raasch W,Bastian C,et al.Endocrine stress parameters during TIVA with remifentanil or sufentanil.Anasthesiol lntensivmed Notfallmed Schmerzther,2000,35:685-691.
